Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Dietmar Hopp
Biotech
Billionaire backs biotech to carve out niche in busy BCMA space
The $41 million extends Heidelberg’s runway out to mid-2023, setting it up to advance its anti-BCMA ADC through a phase 1/2a study.
Nick Paul Taylor
Feb 17, 2022 8:10am
Germany takes a stake in COVID-19 vaccine drugmaker CureVac
Jun 15, 2020 8:25am
Amgen helps Immatics to $58M round to fund cancer trials
Oct 4, 2017 2:51am
Menichella takes charge of CureVac’s U.S. mRNA outpost
May 2, 2017 8:30am
